{"id":201167,"name":"MONTEFIORE MEDICAL CENTER","slug":"montefiore-medical-center","state":"NY","description":"Hospital.","totalSpending":2580000,"filings":29,"yearlySpending":[{"year":2018,"income":240000},{"year":2019,"income":180000},{"year":2020,"income":240000},{"year":2021,"income":270000},{"year":2022,"income":440000},{"year":2023,"income":440000},{"year":2024,"income":440000},{"year":2025,"income":330000}],"firms":["WELSH ROSE, LLC"],"lobbyists":["KATE ROSE","KRISTIN WELSH"],"issues":["MMM","BUD","HCR","INS",null,"DIS"],"sampleDescriptions":["H.R. 1892, Bipartisan Budget Act of 2018, all sections related to the Medicaid program, state options to expand Medicaid and the disproportionate share payment provisions. Issues related to Medicare and Medicaid reimbursement. Issues related to 340B drug pricing.","H.R. 1892, Bipartisan Budget Act of 2018, all sections related to the Medicaid program, state options to expand Medicaid and the disproportionate share payment provisions. Issues related to Title V Maternal and Child Health Services Block Grants.","Issues related to Medicare and Medicaid reform, drug pricing and NIH funding.","Issues related to 340B drug pricing. Issues related to Medicare & Medicaid reimbursement.","Issues related to Medicare and Medicaid reform, drug pricing and NIH funding. Issues related to 42 CFR Part 2. Issues related to school based health center funding.","S. 1531, Stopping The Outrageous Practice of Surprise Medical Bills Act of 2019.","Issues related to Medicare and Medicaid reform, drug pricing and NIH funding. Issues related to 42 CFR Part 2. Issues related to school based health center funding. Issues related to H.R.748/S.3548, CARES Act.","Issues related to 340B drug pricing. Issues related to Medicare & Medicaid reimbursement. Issues related to H.R.748/S.3548, CARES Act.","Issues related to Medicare and Medicaid reform, drug pricing and NIH funding. Issues related to 42 CFR Part 2. Issues related to school based health center funding. Issues related to H.R.748/S.3548, CARES Act. H.R. 133, the Consolidated Appropriations Act of 2021; surprise billing.","Issues related to 340B drug pricing. Issues related to Medicare & Medicaid reimbursement. Issues related to H.R.748/S.3548, CARES Act. H.R. 133, the Consolidated Appropriations Act of 2021 and issues related to COVID relief.","Issues related to 340B drug pricing. Issues related to Medicare & Medicaid disbursement.","Hospital infrastructure funding.","Issues related to private insurance.","Issues related to 340B drug pricing. Issues related to Medicare & Medicaid disbursement. Issues related to The Provider Relief Fund and other Covid costs.","Hospital infrastructure funding. School based health center funding.","Issues related to Medicare and Medicaid reform, drug pricing and NIH funding. Issues related to school-based health center funding. Issues related to Medicare & Medicaid disbursement. Issues related to The Provider Relief Fund and other Covid costs.","Issues related to Medicare and Medicaid reform, drug pricing and NIH funding. Issues related to school-based health center funding. Issues related to Medicare & Medicaid disbursement. Issues related to The Provider Relief Fund and other Covid costs. PDUFA reauthorization and VALID Act.","Issues related to 340B drug pricing. Issues related to Medicare & Medicaid disbursement. Issues related to The Provider Relief Fund and other Covid costs. H.R. 2617 (P.L. 117-328), the Consolidated Appropriations Act of 2023.","Issues related to Medicare and Medicaid reform, drug pricing and NIH funding. Issues related to school-based health center funding. Issues related to Medicare & Medicaid disbursement. Issues related to The Provider Relief Fund and other Covid costs. PDUFA reauthorization and VALID Act. H.R. 2617 (P.L. 117-328), the Consolidated Appropriations Act of 2023.","Issues related to Medicare & Medicaid disbursement. Site-neutral payment policy."],"years":[2018,2019,2020,2021,2022,2023,2024,2025]}